cryptotanshinone has been researched along with Breast Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastow, KF; Don, MJ; Lee, KH; Lin, YL; Nakamura, S; Sun, CM; Wang, X; Wu, TS; Yu, HJ | 1 |
| Chen, M; He, Y; Li, H; Shi, D; Sun, L; Zhang, Z; Zhao, P | 1 |
| Chen, M; Cui, L; Li, H; Niu, J; Shi, D; Sun, L; Zhao, P | 1 |
| Chen, H; Feng, N; He, Y; Hou, X; Liu, Y; Shen, J; Shi, J; Wang, Z; Xie, X | 1 |
| Bittner, M; Datta, A; Hua, J; Lopes, R; Sima, C; Vundavilli, H | 1 |
| Gao, GS; Hu, AR; Hu, YR; Xu, XZ; Zhou, J; Zhu, CL | 1 |
| Bao, LL; Fu, YJ; Huang, XL; Jiang, YH; Maimaitiyiming, Y; Naranmandura, H; Wang, QQ; Zhang, GJ; Zhang, M; Zhang, YF | 1 |
| Hong, L; Huang, F; Li, S; Liu, W; Wang, H; Wang, J; Wang, P; Zhang, X; Zhou, J | 1 |
| Chen, W; Liu, Y; Lu, Y; Ni, W; Pan, Y; Shi, J; Wang, A; Wang, S; Wang, X; Wei, Z | 1 |
| Han, DC; Kim, HN; Kim, SJ; Kwon, BM; Shin, DS; Shin, KD; Yoon, YJ | 1 |
10 other study(ies) available for cryptotanshinone and Breast Neoplasms
| Article | Year |
|---|---|
Antitumor Agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Furans; Humans; Pyrones; Receptor, ErbB-2; Receptors, Estrogen; Salvia miltiorrhiza | 2004 |
Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway.
Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; China; Estrogens; Female; Humans; MCF-7 Cells; Phenanthrenes; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction | 2022 |
Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Phenanthrenes; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction | 2020 |
Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
Topics: Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Caco-2 Cells; Cell Movement; HT29 Cells; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mucus; Nanoparticles; Neoplasms, Experimental; Phenanthrenes; Rats, Sprague-Dawley; Silybin; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
Bayesian Inference Identifies Combination Therapeutic Targets in Breast Cancer.
Topics: Antineoplastic Agents; Apoptosis; Bayes Theorem; Breast Neoplasms; Computational Biology; Drug Discovery; Female; Gene Regulatory Networks; Humans; MCF-7 Cells; Phenanthrenes | 2019 |
Cryptotanshinone induces inhibition of breast tumor growth by cytotoxic CD4+ T cells through the JAK2/STAT4/ perforin pathway.
Topics: Animals; Apoptosis; Blotting, Western; Breast Neoplasms; CD4-Positive T-Lymphocytes; Cell Proliferation; Female; Flow Cytometry; Humans; Interferon-gamma; Janus Kinase 2; Mice; Mice, Inbred C57BL; Perforin; Phenanthrenes; STAT4 Transcription Factor; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
The combination of arsenic and cryptotanshinone induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in breast cancer cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Arsenic; Breast Neoplasms; Cell Line, Tumor; Endoplasmic Reticulum Stress; Female; Humans; Phenanthrenes; Reactive Oxygen Species | 2015 |
Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Models, Molecular; Molecular Docking Simulation; Phenanthrenes; Protein Conformation; Receptors, Estrogen; Signal Transduction; Transcription, Genetic; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor alpha; Female; Humans; Insulin-Like Growth Factor I; Mice, Inbred BALB C; Models, Biological; Molecular Docking Simulation; Phenanthrenes; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |
Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
Topics: bcl-X Protein; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cyclin D1; Dimerization; Down-Regulation; Drugs, Chinese Herbal; HCT116 Cells; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Luciferases; Male; Microtubule-Associated Proteins; Models, Molecular; Phenanthrenes; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; STAT3 Transcription Factor; Stomach Neoplasms; Survivin | 2009 |